Front Row Advisors LLC - ARBUTUS BIOPHARMA CORP ownership

Quarter-by-quarter ownership
Front Row Advisors LLC ownership history of ARBUTUS BIOPHARMA CORP
ValueSharesWeighting
Q3 2023$21,315
+88712.5%
10,5000.0%0.01%
-9.1%
Q2 2023$24
-25.0%
10,5000.0%0.01%
-26.7%
Q1 2023$32
+33.3%
10,5000.0%0.02%
+25.0%
Q4 2022$24
-99.9%
10,5000.0%0.01%
+20.0%
Q3 2022$20,000
-28.6%
10,5000.0%0.01%
-28.6%
Q2 2022$28,000
-9.7%
10,5000.0%0.01%
+16.7%
Q1 2022$31,00010,5000.01%
Other shareholders
ARBUTUS BIOPHARMA CORP shareholders Q4 2023
NameSharesValueWeighting ↓
JACOB ASSET MANAGEMENT OF NEW YORK LLC 340,000$1,459,0000.53%
RTW INVESTMENTS, LP 4,733,323$20,306,0000.31%
APIS CAPITAL ADVISORS, LLC 70,000$300,0000.29%
Hudson Bay Capital Management LP 1,800,000$7,722,0000.10%
COWEN AND COMPANY, LLC 249,215$1,069,0000.05%
Kerrisdale Advisers, LLC 100,000$429,0000.05%
Woodline Partners LP 496,172$2,129,0000.04%
Shay Capital LLC 60,000$257,0000.03%
Walleye Capital LLC 231,037$991,0000.03%
BOOTHBAY FUND MANAGEMENT, LLC 212,700$912,0000.02%
View complete list of ARBUTUS BIOPHARMA CORP shareholders